12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the pre-market movements of various healthcare stocks on Friday. TFF Pharmaceuticals, Centene, and Nexalin Technology are among the gainers, while Monopar Therapeutics and Quince Therapeutics are notable losers.
October 25, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Monopar Therapeutics experienced a significant decline of 23.9% in pre-market trading.
The sharp decline indicates negative sentiment or news, likely leading to a short-term price decrease.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Quince Therapeutics' stock fell by 15.97% in pre-market trading.
The decline suggests negative sentiment or news, impacting the stock price negatively in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Centene's shares rose by 12.62% following the release of their Q3 earnings.
The increase is directly linked to the Q3 earnings release, indicating positive results or outlook.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 85
POSITIVE IMPACT
Nexalin Technology's stock rose by 9.31% in pre-market trading.
The pre-market rise suggests positive investor sentiment, potentially due to news or market conditions.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
TFF Pharmaceuticals saw a significant pre-market increase of 27.9%, indicating strong investor interest.
The substantial pre-market gain suggests positive sentiment or news, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90